UnitedHealth Charts Continued Turnaround

Dow Jones
昨天
 
 

UnitedHealth Group reported earnings that came in above analysts' expectations and again raised its projection for the year, as the healthcare company continued charting a financial turnaround.

The announcement comes more than a year after Chief Executive Stephen Hemsley returned to the top job, promising major changes after a meltdown that cut the company's valuation by hundreds of billions of dollars.

For the third quarter of 2026, UnitedHealth reported net income of $4.11 billion, or $4.56 a share. That compared with net income of $2.35 billion, or $2.59 a share, a year earlier.

UnitedHealth, the parent of the biggest U.S. health insurer and a large array of other healthcare assets, raised its guidance for full-year adjusted earnings to at least $20.50 a share. Last quarter, the company had projected a range of $19.50 to $20. Analysts polled by FactSet had estimated $19.80.

UnitedHealth's adjusted earnings of $4.69 a share in the third quarter topped the $4.14 a share FactSet consensus.

Revenue for the third quarter was $112.69 billion, compared with $113.16 billion a year earlier.

Under Hemsley, its longtime prior CEO who returned to the position after a stint serving solely as chairman, the company has sought to pare unprofitable businesses, reducing the footprint of its sprawling physician-group unit and shrinking its Medicare plans. Its overall health-insurance enrollment is now 48.3 million, down from 50.1 million a year ago.

UnitedHealthcare, the insurance arm, reported a medical-loss ratio of 88.4%, a closely watched number that represents the share of premiums spent on medical costs. The FactSet consensus projection was 89.7%.

The company's main healthcare-provider unit, Optum Health, which was a major part of UnitedHealth's financial woes last year, reported earnings from operations of around $735 million, compared with $41 million a year ago. The company credited "strengthened operational discipline and medical cost management." Optum Health's revenue dropped, as it managed fewer patients in markets where its presence had been thin.

 
 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10